Thanks George
Sad for the loss
That trial was in Phase 1b
Atl1102 is in a Pivitol study in Phase 2b/3
Last trial by Anp was for 6 months
Proved safe and tolerable
Watch the interest now in Anp with Gene Therapy taking a life..
- Forums
- ASX - By Stock
- PER
- UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE
UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-2
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.9¢ | $31.47K | 390.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32000 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 79712 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32000 | 0.079 |
3 | 214126 | 0.078 |
1 | 200000 | 0.077 |
3 | 91500 | 0.076 |
4 | 206988 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 79712 | 6 |
0.082 | 97561 | 1 |
0.083 | 214000 | 1 |
0.084 | 161142 | 2 |
0.085 | 141000 | 2 |
Last trade - 13.04pm 15/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online